首页> 外文期刊>Online Journal of Public Health Informatics >Rabies Vaccination Coverage and Antibody Profile of Owned Dogs in Abuja, Nigeria
【24h】

Rabies Vaccination Coverage and Antibody Profile of Owned Dogs in Abuja, Nigeria

机译:尼日利亚阿布贾狂犬病疫苗接种率和成犬抗体概况

获取原文
           

摘要

Objective To determine the vaccination status of owned dogs, assess the rabies antibody titre of vaccinated dogs and risk factors associated with vaccination of dogs in Abuja, Nigeria. Introduction Rabies is a zoonotic disease of high public health importance 1 . There have been documented reports of rabies in vaccinated dogs 2 . Rabies is enzootic in domestic dogs in Nigeria. Hence, annual vaccination campaigns of dogs are advocated with the aim of rabies elimination. Vaccination status, type of vaccination and the immunogenicity of the various rabies vaccines used in Abuja Nigeria has not been studied. To date, no effective medical therapy has been established for rabies 3 . Most human rabies deaths occur in the developing countries and though effective and economical control measures are available their application in developing countries is hampered by a range of economic, social and political factors. It is widely recognized that the number of deaths officially reported in most developing countries greatly underestimates the true incidence of disease, with several factors contributing to widespread underreporting 3 . Preventive vaccination against rabies virus is a highly effective method for preventing rabies in humans and animals 3 but do people vaccinate and how long does the immunity conferred by the vaccine remain protective in the dogs in Abuja?. Rabies has high financial expenditure burden on any country where it is endemic mainly associated with costs incurred on post-exposure prophylaxis (determined by the type of vaccine, vaccine regimen and route of administration as well as the type of immunoglobulin used). Methods Dog serum samples (n=276) were collected from Abuja the Federal Capital Territory (FCT) Nigeria, from 5 locations (Phase 1, 2, 3, Gwagwalada and Kubwa) based on availability and owners consent. Rabies antibody serum titer was determined using an indirect enzyme linked immuno-sorbent assay. Face to face structured questionnaires were used to obtain demographic and zoographic information from the dog owners. Associations between the demographic variables, vaccination status and rabies antibody titer of each dog were assessed using ?? 2 analysis. Results Of the dogs sampled, 229 (83%) had certified antirabies vaccination record. The dogs sampled, which were vaccinated from Phase I, II, III and the satellite towns were; 109/118 (92.37%), 32/33 (96.97%), 48/49 (97.96%) and 40/76 (52.63%), respectively. A total of 276 serum samples were collected, processed and analyzed during this study. Out of the 276 dogs sampled, 239 (86.6%) had rabies antibody titre a?¥ 0.6EU/ml whilst 37 (13.4%) had less than 0.6EU/ml. There was a marked decline in rabies antibody titre with increase in time. Out of the 228 exotic breeds of dogs sampled, 218 (95.6%) were vaccinated whilst 11 (22.9%) of the 48indigenous breed of dogs sampled were vaccinated. All the exotic breed of dogs had rabies antibody titre a?¥ 0.6EU/ml whilst 37 (77.1%) of the indigenous breed of dogs had less than 0.6 EU/ml levels of rabies antibody titre. All dogs within 6 months to 1 year and greater than 10 years of age had a?¥ 0.6EU/ml rabies antibody titre whilst dogs within 1-5 years had 1 (0.5%) and 36(69.2%) dogs of age 6-10 years had rabies antibody titre & 0.6EU/ml. Twelve (7.6%) of the males and 25 (21.2%) of the females had less than 0.6EU/ml rabies antibody titre. All the dogs acquired by importation and from breeders had rabies antibody titre a?¥ 0.6EU/ml whilst 37 (27.2%) of the dogs acquired from friends had less than 0.6EU/ml rabies antibody titre. Significant associations were observed between breed ( ?? 2 = 203, df = 1, P-value & 0.05), age ( ?? 2 = 172, df = 3, P-value & 0.05), sex ( ?? 2 = 10.75, df = 1, P-value & 0.05), source ( ?? 2 = 43.99, df = 2, P-value & 0.05), rabies vaccination status ( ?? 2 = 276.00,
机译:目的确定尼日利亚阿布贾(Abuja)犬只的疫苗接种状况,评估疫苗接种犬的狂犬病抗体滴度和与犬疫苗接种相关的危险因素。简介狂犬病是一种具有高度公共卫生意义的人畜共患病1。有文献报道疫苗接种狗中出现狂犬病2。狂犬病在尼日利亚的家犬中具有动物共生性。因此,倡导狗的年度疫苗接种运动,以消除狂犬病。尚未研究尼日利亚阿布贾使用的各种狂犬病疫苗的疫苗接种状况,疫苗接种类型和免疫原性。迄今为止,尚未建立有效的狂犬病药物治疗方法3。大多数人类狂犬病死亡发生在发展中国家,尽管有有效的经济控制措施可用,但它们在发展中国家的应用却受到一系列经济,社会和政治因素的阻碍。众所周知,在大多数发展中国家,官方报告的死亡人数大大低估了疾病的真实发生率,其中有许多因素导致普遍的低报3。预防狂犬病病毒的预防性疫苗接种是预防人和动物狂犬病的高效方法3,但是人们会接种疫苗吗?疫苗赋予的免疫力在阿布贾的狗中能起到保护作用?狂犬病在任何地方流行的国家都具有很高的财政支出负担,主要与暴露后预防所产生的费用有关(由疫苗类型,疫苗方案和给药途径以及所用免疫球蛋白的类型决定)。方法根据可获得性和所有者同意,从尼日利亚联邦首都特区(FCT)阿布贾的5个地点(第1、2、3,Gwagwalada和Kubwa阶段)收集狗血清样本(n = 276)。使用间接酶联免疫吸附测定法确定狂犬病抗体的血清滴度。使用面对面的结构化问卷从狗主人那里获得人口统计学和动物学信息。使用Δβ评估每只狗的人口统计学变量,疫苗接种状态和狂犬病抗体滴度之间的关联。 2分析。结果抽检的狗中,有229例(83%)具有经认证的抗狂犬病疫苗接种记录。从第一,第二,第三阶段和附属城镇接种疫苗的犬只是;分别为109/118(92.37%),32/33(96.97%),48/49(97.96%)和40/76(52.63%)。在这项研究中,总共收集,处理和分析了276个血清样品。在276只狗中,有239只(86.6%)的狂犬病抗体滴度为0.6EU / ml,而37只(13.4%)的狂犬病抗体滴度低于0.6EU / ml。随着时间的增加,狂犬病抗体滴度显着下降。在228种外来犬种中,有218例(95.6%)进行了疫苗接种,而在48种本地犬种中有11种(22.9%)进行了疫苗接种。所有外来犬品种的狂犬病抗体滴度均≥0.6EU / ml,而本土犬中有37(77.1%)狂犬病抗体滴度低于0.6 EU / ml。在6个月至1岁之间且年龄大于10岁的所有狗的狂犬病抗体滴度为0.6EU / ml,而1-5岁以内的狗的6岁至1岁(0.5%)和36(69.2%) 10年狂犬病抗体滴度& 0.6EU /毫升。男性中有十二名(7.6%),女性中有25名(21.2%)狂犬病抗体滴度低于0.6EU / ml。通过进口和从种犬那里获得的所有狗的狂犬病抗体滴度均≥0.6EU / ml,而从朋友那里获得的狗中有37只(27.2%)的狂犬病抗体滴度低于0.6EU / ml。在品种(?? 2 = 203,df = 1,P值<0.05),年龄(?? 2 = 172,df = 3,P值<0.05)之间,性别(?? 2 = 10.75,df = 1,P值<0.05),来源(Δ2 = 43.99,df = 2,P值<0.05),狂犬病疫苗接种状况(Δ2 = 276.00,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号